These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 28705706)
1. Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions. Tanaka M; Kohashi K; Kushitani K; Yoshida M; Kurihara S; Kawashima M; Ueda Y; Souzaki R; Kinoshita Y; Oda Y; Takeshima Y; Hiyama E; Taguchi T; Tanaka Y Hum Pathol; 2017 Aug; 66():177-182. PubMed ID: 28705706 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel ALK rearrangement A2M-ALK in a neonate with fetal lung interstitial tumor. Onoda T; Kanno M; Sato H; Takahashi N; Izumino H; Ohta H; Emura T; Katoh H; Ohizumi H; Ohtake H; Asao H; Dehner LP; Hill AD; Hayasaka K; Mitsui T Genes Chromosomes Cancer; 2014 Oct; 53(10):865-74. PubMed ID: 24965693 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous Partial Regression of Fetal Lung Interstitial Tumor With Tan-Garcia A; Lee YT; Kuick CH; Soh SY; Chang KT; Merchant K Pediatr Dev Pathol; 2024; 27(2):187-192. PubMed ID: 37818649 [TBL] [Abstract][Full Text] [Related]
4. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
5. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature. Fu X; Jiang J; Tian XY; Li Z Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751 [TBL] [Abstract][Full Text] [Related]
8. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation. Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150 [TBL] [Abstract][Full Text] [Related]
10. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report. Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068 [TBL] [Abstract][Full Text] [Related]
12. Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry. Wang J; Shen Q; Shi Q; Yu B; Wang X; Cheng K; Lu G; Zhou X J Exp Clin Cancer Res; 2014 Dec; 33(1):109. PubMed ID: 25527865 [TBL] [Abstract][Full Text] [Related]
13. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis. Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079 [TBL] [Abstract][Full Text] [Related]
14. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors. Hornick JL; Sholl LM; Dal Cin P; Childress MA; Lovly CM Mod Pathol; 2015 May; 28(5):732-9. PubMed ID: 25612511 [TBL] [Abstract][Full Text] [Related]
15. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor. Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942 [TBL] [Abstract][Full Text] [Related]
16. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder. Inamura K; Kobayashi M; Nagano H; Sugiura Y; Ogawa M; Masuda H; Yonese J; Ishikawa Y Hum Pathol; 2017 Nov; 69():96-100. PubMed ID: 28504207 [TBL] [Abstract][Full Text] [Related]
17. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011 [TBL] [Abstract][Full Text] [Related]
18. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay. Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999 [TBL] [Abstract][Full Text] [Related]
19. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137 [TBL] [Abstract][Full Text] [Related]
20. Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas. Wagner F; Streubel A; Roth A; Stephan-Falkenau S; Mairinger T J Clin Pathol; 2014 May; 67(5):403-7. PubMed ID: 24293609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]